NCT01919944View on ClinicalTrials.gov

Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Pruritus
Interventions
DRUG

VLY-686

capsules containing either 10 mg or 50 mg VLY-686

DRUG

Placebo

Sugar capsule to mimic either VLY-686 10 mg capsule or 50 mg capsule

Trial Locations (1)

CH 6864

Vanda Investigational Site, Arzo

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY